Skip to main content

Table 2 Differential miRNA expression between groups in CSF

From: Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions

 

Gd (n = 20)

Gd + (n = 26)

 

Median

Q1-Q3

Median

Q1–Q3

p value

miR-21

0.014

0.010–0.022

0.029

0.013–0.052

0.024

miR-146a

0.065

0.031–0.136

0.135

0.082–0.239

0.016

miR-146b

0.008

0.002–0.020

0.021

0.012–0.052

0.030

miR-155

0.007

0.002–0.016

0.011

0.006–0.019

0.163

miR-223

0.066

0.043–0.328

0.124

0.088–0.226

0.232

miR-320

0.038

0.010–0.048

0.042

0.026–0.087

0.271

miR-328

0.007

0.003–0.012

0.011

0.005–0.026

0.143

  1. Gd− patients without gadolinium-enhanced lesions, Gd+ patients with gadolinium-enhanced lesions; Q1–Q3 first quartile–third quartile